Who we are
In most neurodegenerative diseases we lose connections - synapses – between neurons, a process that contributes to declines in cognition and motor function that characterize these diseases. At Spinogenix we are developing first-in-class, novel small molecule drugs (SPGs) that restore synapses to improve and potentially restore cognitive and motor function. Our approach is unique for diseases of the central nervous system.
Mission
Our mission is to create transformative therapeutics for diseases involving synaptic loss and dysfunction. Our approach is focused on regenerating synapses to reverse declines in cognitive and motor function. This approach is unique among the many therapeutics that are being developed for neurodegenerative conditions, which mostly aim to slow the degenerative process. We envision the use of SPGs as a monotherapy or in combination with other therapeutics that target disease-specific degenerative processes.
Our Science
In contrast to much research focused on alleviating the symptoms of neurodegenerative disease, we seek to develop therapies that impact the underlying disease and fundamentally change treatment paradigms by restoring neuronal connections regardless of the underlying cause of synapse loss. Spinogenix has discovered compounds (SPGs) that restore lost synapses. We have demonstrated the effectiveness of these “spinogenic” molecules in cells and in multiple animal models of neurodegeneration. SPGs have a novel molecular target and their mechanism of action is well understood and unique. This mechanism would be operative in all diseases where synapse loss occurs, irrespective of the pathological basis of synapse loss.
Company Details
- Founded
- -
- Address
- 1901 Avenue Of The Stars, Los Angeles,california 90067,united States
- Phone
- 858-263-3252
- vi****@****nix.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- spinogenix.com
- Keywords
- Therapeutics, Neurodegeneration, Amyloids, Neurorestorative, ALS, Schizophrenia, Depression, Alzheimer's, Parkinson's, Synapses.
- HQ
- Los Angeles, California
Spinogenix, Inc. Questions
Spinogenix, Inc.'s helpline number is 858-263-3252
Spinogenix, Inc.'s website is spinogenix.com
Spinogenix, Inc.'s LinkedIn profile is https://www.linkedin.com/company/spinogenix
Spinogenix, Inc.'s industry is
Biotechnology Research
Spinogenix, Inc.'s top competitors are
Marvel Biosciences Corp.,
Neurizon,
Trefoil Therapeutics,
Vanda Pharmaceuticals,
Grin Therapeutics, Inc.,
Amydis, Inc.,
Alterity Therapeutics,
Stead Impact Ventures And Foundation,
Renovorx (Nasdaq: Rnxt),
Mira Pharmaceuticals.
Spinogenix, Inc.'s support email address is vince@spinogenix.com
Spinogenix, Inc.'s categories are Biotechnology Research
Spinogenix, Inc.'s founding year is 2016
